ASDIN white paper: Assessment and management of hemodialysis access-induced distal ischemia by interventional nephrologists.


Journal

The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 31 12 2019
medline: 6 10 2020
entrez: 31 12 2019
Statut: ppublish

Résumé

Although not common, hemodialysis access-induced distal ischemia is a serious condition resulting in significant hemodialysis patient morbidity. Patients with signs and symptoms suggestive of hand ischemia frequently present to the general and interventional nephrologist for evaluation. In order to care for these cases, it is necessary to understand this syndrome and its management. Most cases can be managed conservatively without intervention. Some cases requiring intervention may be treated using techniques within the scope of practice of the interventional nephrologists while other cases require vascular surgery. In order for the interventional nephrologists to evaluate and manage these cases in a timely and appropriate manner, practice guidelines are presented.

Identifiants

pubmed: 31884872
doi: 10.1177/1129729819894774
doi:

Types de publication

Editorial Practice Guideline Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

543-553

Auteurs

Gerald A Beathard (GA)

University of Texas Medical Branch, Galveston, TX, USA.

William C Jennings (WC)

School of Community Medicine, The University of Oklahoma, Tulsa, OK, USA.

Haimanot Wasse (H)

Rush University Medical Center, Chicago, IL, USA.

Surendra Shenoy (S)

Barnes-Jewish Hospital, Washington University, St. Louis, MO, USA.

Dirk M Hentschel (DM)

Renal Division, Brigham Health, Boston, MA, USA.

Kenneth Abreo (K)

School of Medicine, LSU Health Shreveport, Shreveport, LA, USA.

Aris Urbanes (A)

Internal Medicine, Wayne State University, Detroit, MI, USA.

George Nassar (G)

Weill Cornell Medicine, New York, NY, USA.
Houston Methodist Hospital, Houston, TX, USA.

Bart Dolmatch (B)

Palo Alto Medical Foundation, Palo Alto, CA, USA.

Ingemar Davidson (I)

University of Texas Southwestern Medical Center, Dallas, TX, USA.

Arif Asif (A)

Hackensack Meridian School of Medicine at Seton Hall University, Nutley, NJ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH